One-Year Clinical Outcome of Inspiron Stent in All-Comers Population (Analysis from 790 Consecutive Patients).

Aims: The goal of this study was to evaluate the performance of the Inspiron coronary stent (Scitech Medical™, Goiás, Brazil). The Inspiron sirolimus-eluting stent uses an ultrathin L-605 cobalt-chromium alloy with a 75 m strut thickness platform coated with an abluminal biodegradable polymer. The polymer is eliminated from the body through the tricarboxylic acid cycle in 6-9 months, releasing 80% of the drug within 30 days after its deployment.